All Products
B
M
R
S
U
W
Z
Find industry news, trends, and innovative products right here in our blog.
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
V
W
X
Vabysmo (faricimab-svoa) is administered via intravitreal injection with flexible dosing intervals. After an initial loading phase of four monthly doses, treatment can...
Vabysmo (faricimab-svoa) is developed and manufactured by Genentech, a member of the Roche Group. As a leader in biotechnology, Genentech brings decades...
Learn the recommended Vabysmo dosing and treatment frequency, plus what patients can expect during therapy for retinal conditions.
Find out whether Vabysmo is a steroid, how it works, and what makes it different from steroid-based eye treatments.
Learn about Vabysmo, its generic name Faricimab-svoa, how it works, and its role in treating retinal eye conditions.
Vabysmo (faricimab-svoa) is a bispecific antibody injection used to treat wet AMD, DME, and retinal vein occlusion. It works by blocking VEGF-A...
Compare Vabysmo and Eylea, two leading anti-VEGF injections for retinal diseases. Learn how their mechanisms, dosing schedules, and clinical outcomes differ in...
Explore the full range of Vabysmo (faricimab) side effects, from common issues like eye pain and conjunctival hemorrhage to rare but serious...